Sayali Onkar, a 3rd year graduate student in the lab, was awarded the “Biomedical Graduate Student Association (BGSA) Travel Award” for her abstract and oral presentation as well as “Best Poster” at Translational Research Cancer Center Consortium (TRCCC) in Seven Springs, PA.
The Lee-Oesterreich Lab worked hard and played hard at the SABCS 2018!
Becky Watters receiving her white coat for her Komen award Becky Watters receiving her white coat for her Komen award Leisha Emens giving an oral presentation
Dr. Adrian Lee was recently interviewed for the “Do-Goodery Podcast: The Cancer Episode” to, as described by their website, “discuss what a jerk Cancer is. We Take Astro 101, learn about new weapons in the fight against Cancer, and how to support those who’ve received a Cancer diagnosis.”
Listen here:
Behold! The #Cancer Episode of The Do-Goodery Podcast!@PittTweet‘s Dr. Adrian Lee, a leading Cancer researcher, on the new weapons we have to fight it in this Golden Era of Cancer research.@OurClubhousePA on how to support those affected by Cancer.https://t.co/5OmJlL9ciw
— Rocco DeMaro (@RoccoDeMaro) November 12, 2018
Steffi meets with members of LBCA advocacy group (https://lobularbreastcancer.org/), and discusses progress and challenges for ILC research at the Northwest Metastatic Breast Cancer Conference (NWMBCC).
The presentation was live streamed, and can be seen here: https://www.facebook.com/lobularbreastcanceralliance/videos/553742191751845/.
Of note, Leigh Pate, founder of LBCA, receives the Beth Caldwell Breakthrough Leadership award.
Congrats to Nilgun Tasdemir for the Excellence in Research Travel Award she received from the Endocrine Society at the 8th Great Lakes Nuclear Receptor Conference (GLNRC) held at the University of Minnesota on October 18-19, 2018.
We provide evidence that loss of E-cadherin hyperactivates the IGF1R pathway and increases sensitivity to IGF1R/InsR targeted therapy, thus identifying the IGF1R pathway as a potential novel target in E-cadherin–deficient breast cancers such as invasive lobular cancer.